Pathstone Holdings’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$591K Buy
7,646
+1,450
+23% +$104K ﹤0.01% 1783
2026
Q1
$436K Hold
6,196
﹤0.01% 1808
2025
Q4
$460K Sell
6,196
-5,562
-47% -$400K ﹤0.01% 1779
2025
Q3
$786K Sell
11,758
-4,094
-26% -$264K ﹤0.01% 1554
2025
Q2
$1.01M Sell
15,852
-10,687
-40% -$681K ﹤0.01% 1384
2025
Q1
$1.83M Sell
26,539
-3,491
-12% -$240K 0.01% 1034
2024
Q4
$1.96M Buy
30,030
+8,414
+39% +$585K 0.01% 982
2024
Q3
$1.57M Buy
21,616
+16
+0.1% +$1.15K 0.01% 1123
2024
Q2
$1.48M Buy
21,600
+364
+2% +$24.6K 0.01% 1078
2024
Q1
$1.48M Buy
21,236
+11,748
+124% +$796K 0.01% 1053
2023
Q4
$613K Buy
+9,488
New +$580K ﹤0.01% 1376

Other funds holding FHLC

Pathstone Holdings's FHLC Position: Q2 2026 in Review

Pathstone Holdings increased its Fidelity MSCI Health Care Index ETF (FHLC) stake by 23% in Q2 2026, buying an estimated $104K and bringing the position to 7,646 shares worth $591K. The position accounts for ﹤0.01% of the portfolio, ranked #1783.

Pathstone Holdings first reported a position in FHLC in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.96M in Q4 2024. 382 funds tracked by Wall St. Rank hold FHLC as of Q2 2026.

  • Pathstone Holdings held 7,646 shares of Fidelity MSCI Health Care Index ETF worth $591K as of Q2 2026.
  • Pathstone Holdings bought 1,450 Fidelity MSCI Health Care Index ETF shares in Q2 2026, an estimated $104K.
  • Fidelity MSCI Health Care Index ETF made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1783 holding.
  • Pathstone Holdings first reported a position in Fidelity MSCI Health Care Index ETF in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Fidelity MSCI Health Care Index ETF position peaked at $1.96M in Q4 2024.
  • 382 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.